Business
Allotment of Shares
Allotment of Shares.
About this update from Hemogenyx Pharmaceuticals Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 7174T\n Hemogenyx Pharmaceuticals PLC\n 29 March 2021\n \n \n \n 29 March 2021\n \n \n Hemogenyx Pharmaceuticals plc \n (\"Hemogenyx Pharmaceuticals\" or the \"Company\")\n \n Allotment of Shares\n \n \n Hemogenyx Pharmaceuticals plc (LSE: HEMO) \n announces \n that it has allotted 1,000,000 new ordinary shares of £0.01 each in the Company (\"Ordinary Shares\") in consideration for finance consulting services to Prosdocimi Limited\n .\n \n \n \n \nAn application has been made to the London Stock Exchange Main Market and admission of the new Ordinary Shares to trading is expected on or around 6 April 2021 (\"Admission\"). The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in the Company.\n \n \n \n \n \n \n \n \n Total Voting Rights\n \n \n \n \n \n Following Admission of the new Ordinary Shares, together with the new Ordinary Shares allotted to Mint Capital announced on 26 March 2021 and that are also expected to be admitted to trading on or around 6 April 2021, the Company will have 469,795,217 Ordinary Shares of £0.01 each in issue with voting rights. The Company does not hold any shares in treasury. This figure may then be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.\n \n \n \n \n \n \n \n \n \n \n \n \n \n Enquiries:\n \n \n \n \n \n Hemogenyx Pharmaceuticals plc\n \n \n \n \n \n https://hemogenyx.com\n \n \n \n \n \n \n \n Dr Vladislav Sandler, Chief Executive Officer & Co-Founder\n \n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n Peter Redmond, Director\n \n \n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n SP Angel Corporate Finance LLP\n \n \n \n \n Tel: +44 (0)20 3470 0470\n \n \n \n \n \n \n Matthew Johnson, Vadim Alexandre, Adam Cowl\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Peterhouse Capital Limited\n \n \n \n \n Tel: +44 (0)20 7469 0930\n \n \n \n \n \n \n Lucy Williams, Duncan Vasey, Charles Goodfellow\n \n \n \...